{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:09:55Z","timestamp":1730434195892,"version":"3.28.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The aim of this study was to verify whether exaggerated arrhythmogenesis is attributed to inflammatory factors actively involving an excess of reactive oxygen species (ROS), transforming growth factor (TGF)-\u03b2 and endothelin (ET). We hypothesized that CPU86017, derived from berberine, which possesses multi-channel blocking activity, could suppress inflammatory factors, resulting in inhibition of over-expression of ether-a-go-go (ERG) and an augmented incidence of ventricular fibrillation (VF) in ischaemia\/reperfusion (I\/R). Rats with cardiomyopathy (CMP) induced by thyroxine (0.2 mg\u22121kg\u22121 s.c. daily for 10 days) were treated with propranolol (10 mg kg\u22121 p.o.) or CPU86017 (80 mg kg\u22121 p.o.) on days 6\u201310. On the 11th day, arrhythmogenesis of the CMP was evaluated by I\/R. In the CMP control group, an increase in VF incidence was found with the I\/R episode, accompanied by increased ROS, which manifested as an increased level of malondialdehyde and decreased activities of SOD, glutathione peroxidase and catalase in the myocardium. Levels of inducible nitric oxide synthase and TGF-\u03b2 mRNA were increased in association with upregulation of preproET-1 and ET- converting enzyme. We found increased levels of ERG, which correlated well with arrhythmogenesis. Treatment with CPU86017 or propranolol reversed these changes. These experiments verified our hypothesis that the inflammatory factors ROS, iNOS, TGF-\u03b2 and ET-1 are actively involved in upregulation of ERG and arrhythmogenesis. CPU86017 and propranolol reduced VF by suppressing these inflammatory factors in the myocardium.<\/jats:p>","DOI":"10.1211\/jpp.60.8.0015","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T01:47:27Z","timestamp":1215740847000},"page":"1089-1095","source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent"],"prefix":"10.1093","volume":"60","author":[{"given":"Rong-Hui","family":"Du","sequence":"first","affiliation":[{"name":"Medical college of Nanjing University , Nanjing, 210093,","place":["China"]},{"name":"Research Division of Pharmacology, China Pharmaceutical University , Nanjing, 210009,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wei","family":"Yi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University , Nanjing, 210093,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Zai","family":"Dai","sequence":"additional","affiliation":[{"name":"Research Division of Pharmacology, China Pharmaceutical University , Nanjing, 210009,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hua","family":"Tang","sequence":"additional","affiliation":[{"name":"Medical college of Nanjing University , Nanjing, 210093,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Dai","sequence":"additional","affiliation":[{"name":"Research Division of Pharmacology, China Pharmaceutical University , Nanjing, 210009,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,8,1]]},"reference":[{"key":"2024103109370985300_cit1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-2952(96)00212-2","article-title":"Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils","volume":"52","author":"Anderson","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"2024103109370985300_cit2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11936-006-0043-5","article-title":"Congenital long QT syndrome: diagnosis and management in pediatric patients","volume":"8","author":"Bar-Cohen","year":"2006","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"2024103109370985300_cit3","first-page":"139","article-title":"Extraction of RNA from cells and tissue","volume":"108","author":"Bird","year":"2005","journal-title":"Methods Mol. Med."},{"key":"2024103109370985300_cit4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2796.2005.01582.x","article-title":"The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation","volume":"259","author":"Cerrone","year":"2006","journal-title":"J. Intern. Med."},{"key":"2024103109370985300_cit5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"2024103109370985300_cit6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1527-3466.2006.00101.x","article-title":"CPU-86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels","volume":"24","author":"Dai","year":"2006","journal-title":"Cardiovasc. Drug. Rev."},{"key":"2024103109370985300_cit7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1745-7254.2005.00134.x","article-title":"Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias","volume":"26","author":"Dai","year":"2005","journal-title":"Acta. Pharmacol. Sin."},{"key":"2024103109370985300_cit8","first-page":"416","article-title":"Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017","volume":"25","author":"Dai","year":"2004","journal-title":"Acta. Pharmacol. Sin."},{"key":"2024103109370985300_cit9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ddr.10410","article-title":"CPU-86017 improves the compromised blood-brain barrier permeability mediated by impaired endothelial NO system and oxidative stress caused by L-Thyroxin","volume":"64","author":"Du","year":"2005","journal-title":"Drug Dev. Res."},{"key":"2024103109370985300_cit10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1745-7254.2007.00650.x","article-title":"Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors","volume":"28","author":"Feng","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"2024103109370985300_cit11","first-page":"306","article-title":"Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy","volume":"59","author":"Feng","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"2024103109370985300_cit12","first-page":"10.2A","article-title":"One-dimensional SDS gel electrophoresis of proteins","volume":"10","author":"Gallagher","year":"2006","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"2024103109370985300_cit13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00029330-200702010-00001","article-title":"QT hysteresis in long-QT syndrome children with exercise testing","volume":"120","author":"Gao","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2024103109370985300_cit14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/138620706777698481","article-title":"Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity","volume":"9","author":"Geronikaki","year":"2006","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"2024103109370985300_cit15","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/eurheartj\/ehl185","article-title":"Short QT syndrome: clinical findings and diagnostic-therapeutic implications","volume":"27","author":"Giustetto","year":"2006","journal-title":"Eur. Heart. J."},{"key":"2024103109370985300_cit16","first-page":"417","article-title":"An exaggerated oxidative stress is induced in the myocardium by L-thyroxin and suppressed by CPU86017, a derivative of tetrahydroberberine","volume":"29","author":"Hao","year":"2005","journal-title":"Adv. Pharmacy (Chinese)"},{"key":"2024103109370985300_cit17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"issue":"5 Suppl 1","key":"2024103109370985300_cit18","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1097\/00005344-200036051-00093","article-title":"Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias","volume":"36","author":"Horkay","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2024103109370985300_cit19","first-page":"576","article-title":"Inhibitory effect of berberine on potassium channels in guinea pig ventricular myocytes (Chinese)","volume":"29","author":"Hua","year":"1994","journal-title":"Yao Xue Xue Bao"},{"key":"2024103109370985300_cit20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: understanding the role of transforming growth factor-\u03b21 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"2024103109370985300_cit21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.47102\/annals-acadmedsg.V36N6p394","article-title":"Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family","volume":"36","author":"Koo","year":"2007","journal-title":"Ann. Acad. Med. Singapore"},{"key":"2024103109370985300_cit22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","article-title":"The anti-inflammatory potential of berberine in vitro and in vivo","volume":"203","author":"Kuo","year":"2004","journal-title":"Cancer Lett."},{"key":"2024103109370985300_cit23","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1073\/pnas.0602133103","article-title":"Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias","volume":"103","author":"Lehnart","year":"2006","journal-title":"Proc. Natl Acad. Sci."},{"key":"2024103109370985300_cit24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"2024103109370985300_cit25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1570161043476528","article-title":"Effects of endothelins on cardiac and vascular cells: new therapeutic target for the future?","volume":"2","author":"Moh\u00e1csi","year":"2004","journal-title":"Curr. Vasc. Pharmacol."},{"key":"2024103109370985300_cit26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00210-007-0134-1","article-title":"Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU-86017","volume":"375","author":"Na","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2024103109370985300_cit27","first-page":"627","article-title":"Prevention of sudden death in congenital long-QT syndrome","volume":"18","author":"Oliveira","year":"1999","journal-title":"Rev. Port. Cardiol."},{"key":"2024103109370985300_cit28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/047002142X.ch15","article-title":"The long QT syndrome: a clinical counterpart of hERG mutations","volume":"266","author":"Schwartz","year":"2005","journal-title":"Novartis. Found. Symp."},{"key":"2024103109370985300_cit29","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1073\/pnas.94.21.11698","article-title":"Regulation of the human ether-a-go-go related gene (HERG) K1 channels by reactive oxygen species","volume":"94","author":"Taglialatela","year":"1997","journal-title":"Proc. Natl Acad. Sci."},{"key":"2024103109370985300_cit30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0006-2952(98)00002-1","article-title":"Human ether-a-go-go related gene (HERG) K1 channels as pharmacological targets - present and future implications","volume":"55","author":"Taglialatela","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"2024103109370985300_cit31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cardiores.2003.12.026","article-title":"Pharmacology of cardiac potassium channels","volume":"62","author":"Tamargo","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"2024103109370985300_cit32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/eurheartj\/ehm068","article-title":"Leaky ryanodine receptors cause delayed afterdepolarizations and ventricular arrhythmias","volume":"8","author":"Wehrens","year":"2007","journal-title":"Eur. Heart J."},{"key":"2024103109370985300_cit33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/14728222.11.3.321","article-title":"The hERG potassium channel as a therapeutic target","volume":"11","author":"Witchel","year":"2007","journal-title":"Expert. Opin. Ther. Targets"},{"key":"2024103109370985300_cit34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11886-004-0041-8","article-title":"Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death","volume":"6","author":"Wolbrette","year":"2004","journal-title":"Curr. Cardiol. Rep."},{"key":"2024103109370985300_cit35","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.lfs.2006.06.007","article-title":"Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in 1-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats","volume":"79","author":"Xia","year":"2006","journal-title":"Life Sci."},{"key":"2024103109370985300_cit36","first-page":"515","article-title":"Effects of berberine of L- and T-type calcium channels in guinea pig ventricular myocytes","volume":"18","author":"Xu","year":"1997","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"2024103109370985300_cit37","first-page":"71","article-title":"Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats","volume":"18","author":"Yu","year":"1997","journal-title":"Acta Pharmacol. Sin."},{"key":"2024103109370985300_cit38","first-page":"451","article-title":"Rapidly activating delayed rectifier K+ current in cardiomyocytes from hypertrophied guinea pig hearts induced by thyroxin","volume":"31","author":"Zhang","year":"2000","journal-title":"J. China. Pharma. Univ."},{"key":"2024103109370985300_cit39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.fjc.0000184470.58047.79","article-title":"Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway","volume":"46","author":"Zhang","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.60.8.0015","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/60\/8\/1089\/60257227\/jpp.60.8.0015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/60\/8\/1089\/60257227\/jpp.60.8.0015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:58:15Z","timestamp":1730368695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/60\/8\/1089\/6147726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,8,1]]},"published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.60.8.0015","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[2008,8]]},"published":{"date-parts":[[2008,8,1]]}}}